Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025733231> ?p ?o ?g. }
- W2025733231 endingPage "204" @default.
- W2025733231 startingPage "189" @default.
- W2025733231 abstract "Leukodystrophies are a group of disorders characterized by myelin dysfunction, either at the level of myelin formation or maintenance, that affect the central nervous system (CNS) and also in some cases, to a lesser extent, the peripheral nervous system (PNS). Although these genetic-based disorders are generally rare, all together they have a significant impact in the society, with an estimated overall incidence of 1 in 7,663 live births. Currently, there is no cure for leukodystrophies, and the development of effective treatments remains challenging. Not only leukodystrophies generally progress very fast, but also most are multifocal needing the simultaneous targeting at multiple sites. Moreover, as the CNS is affected, the blood–brain barrier (BBB) limits the efficacy of treatment. Recently, interest on cell therapy has increased, and the leukodystrophies for which metabolic correction is needed have become first-choice candidates for cell-based clinical trials. In this review, we present and discuss the available cell transplantation therapies in metabolic leukodystrophies including fucosidosis, X-linked adrenoleukodystrophy, metachromatic leukodystrophy, Canavan disease, and Krabbe's disease. We will discuss the latest advances of cell therapy and its pitfalls in this group of disorders, taking into account, among others, the limitations imposed by reduced cell migration in multifocal conditions, the need to achieve corrective enzyme threshold levels, and the growing awareness that not only myelin but also the associated axonopathy needs to be targeted in some leukodystrophies." @default.
- W2025733231 created "2016-06-24" @default.
- W2025733231 creator A5006888400 @default.
- W2025733231 creator A5026015985 @default.
- W2025733231 creator A5034241498 @default.
- W2025733231 creator A5084526229 @default.
- W2025733231 date "2013-02-01" @default.
- W2025733231 modified "2023-09-27" @default.
- W2025733231 title "Advances and Pitfalls of Cell Therapy in Metabolic Leukodystrophies" @default.
- W2025733231 cites W1548436366 @default.
- W2025733231 cites W1559433861 @default.
- W2025733231 cites W1956831573 @default.
- W2025733231 cites W1965227495 @default.
- W2025733231 cites W1965425745 @default.
- W2025733231 cites W1966355534 @default.
- W2025733231 cites W1966486881 @default.
- W2025733231 cites W1971989809 @default.
- W2025733231 cites W1972171120 @default.
- W2025733231 cites W1972463612 @default.
- W2025733231 cites W1972797859 @default.
- W2025733231 cites W1972866355 @default.
- W2025733231 cites W1972905629 @default.
- W2025733231 cites W1975053197 @default.
- W2025733231 cites W1976594720 @default.
- W2025733231 cites W1983719481 @default.
- W2025733231 cites W1985776268 @default.
- W2025733231 cites W1986160435 @default.
- W2025733231 cites W1987919833 @default.
- W2025733231 cites W1991062038 @default.
- W2025733231 cites W1992444759 @default.
- W2025733231 cites W1992517468 @default.
- W2025733231 cites W1995455818 @default.
- W2025733231 cites W1999474713 @default.
- W2025733231 cites W2000841826 @default.
- W2025733231 cites W2006986081 @default.
- W2025733231 cites W2008239986 @default.
- W2025733231 cites W2012428359 @default.
- W2025733231 cites W2014600125 @default.
- W2025733231 cites W2015217404 @default.
- W2025733231 cites W2015551558 @default.
- W2025733231 cites W2016140784 @default.
- W2025733231 cites W2016199387 @default.
- W2025733231 cites W2018827685 @default.
- W2025733231 cites W2021033622 @default.
- W2025733231 cites W2021674897 @default.
- W2025733231 cites W2022943511 @default.
- W2025733231 cites W2023378999 @default.
- W2025733231 cites W2025185410 @default.
- W2025733231 cites W2026458516 @default.
- W2025733231 cites W2026939117 @default.
- W2025733231 cites W2028544693 @default.
- W2025733231 cites W2031688326 @default.
- W2025733231 cites W2035574918 @default.
- W2025733231 cites W2035814440 @default.
- W2025733231 cites W2037167329 @default.
- W2025733231 cites W2037386499 @default.
- W2025733231 cites W2039294355 @default.
- W2025733231 cites W2041229020 @default.
- W2025733231 cites W2041755982 @default.
- W2025733231 cites W2043018720 @default.
- W2025733231 cites W2047877587 @default.
- W2025733231 cites W2048255364 @default.
- W2025733231 cites W2048411308 @default.
- W2025733231 cites W2049644653 @default.
- W2025733231 cites W2052693837 @default.
- W2025733231 cites W2052730810 @default.
- W2025733231 cites W2057729851 @default.
- W2025733231 cites W2062164026 @default.
- W2025733231 cites W2063974333 @default.
- W2025733231 cites W2066284508 @default.
- W2025733231 cites W2066705764 @default.
- W2025733231 cites W2066859433 @default.
- W2025733231 cites W2068199432 @default.
- W2025733231 cites W2072407644 @default.
- W2025733231 cites W2075598928 @default.
- W2025733231 cites W2076900342 @default.
- W2025733231 cites W2078277038 @default.
- W2025733231 cites W2078576948 @default.
- W2025733231 cites W2079619166 @default.
- W2025733231 cites W2080941825 @default.
- W2025733231 cites W2081432303 @default.
- W2025733231 cites W2082208518 @default.
- W2025733231 cites W2082279795 @default.
- W2025733231 cites W2084597120 @default.
- W2025733231 cites W2084680109 @default.
- W2025733231 cites W2088438660 @default.
- W2025733231 cites W2088964957 @default.
- W2025733231 cites W2089627637 @default.
- W2025733231 cites W2091730673 @default.
- W2025733231 cites W2092822136 @default.
- W2025733231 cites W2093677350 @default.
- W2025733231 cites W2094319315 @default.
- W2025733231 cites W2094635642 @default.
- W2025733231 cites W2095666785 @default.
- W2025733231 cites W2095718298 @default.
- W2025733231 cites W2098870560 @default.
- W2025733231 cites W2099862428 @default.
- W2025733231 cites W2102310805 @default.